Pneumococcal Polysaccharide Vaccine Solution for Injection 25mcg/0.5ml

Nazione: Malta

Lingua: inglese

Fonte: Medicines Authority

Principio attivo:

PNEUMOCOCCAL POLYSACCHARIDE, SEROTYPE, CONJUGATED TO, CRM, B CONJUGATED, TO CRM, F CONJUGATED, N CONJUGATED, V CONJUGATED, A CONJUGATED, C CONJUGATED

Commercializzato da:

Central Procurement & Supplies Unit UB002 Industrial Estate, San Gwann SGN 3000, Malta

Codice ATC:

J07AL01

INN (Nome Internazionale):

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F CONJUGATED TO CRM197 50 µg/ml

Forma farmaceutica:

SOLUTION FOR INJECTION

Composizione:

PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 1 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 2 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 3 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 4 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 5 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 6B CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 7F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9N CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 9V CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 10A CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 11A CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 12F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 14 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 15B CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 17F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 18C CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19A CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 19F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 20 CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 22F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 23F CONJUGATED TO CRM197 50 µg/ml PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 33F CONJUGATED TO CRM197 50 µg/ml

Tipo di ricetta:

POM

Area terapeutica:

VACCINES

Dettagli prodotto:

Licence number in the source country: United Kingdom - PL00025/0633

Stato dell'autorizzazione:

Authorised

Data dell'autorizzazione:

2019-05-20